Filter by: Subject

Filter by: Subject

Results Per Page:

Lung cancer (1)
Lung lesions (1)
Lymphomas -- Treatment (1)
Male (1)
Mass spectrometry (1)
Medical imaging (1)
Medical problems (1)
Medicine (1)
Medicine -- Scholarships, fellowships, etc. -- South Africa (1)
Menstrual cycle (1)
Metabolic parameters (1)
Metabolic superscan (1)
Metabolic tumor volume (MTV) (1)
Metabolic volume (MV) (1)
Metastasized castration-resistant prostate cancer (mCRPC) (1)
Metastatic castrate-resistant prostate cancer (1)
Metastatic castration-resistant prostate cancer (mCRPC) (1)
MIBI (1)
Microemulsion (1)
Minimal toxicity (1)
Morbidity (1)
Mortality (1)
Multi-modality imaging (1)
Multidrug-resistant (MDR) (1)
Multiple substitutions (1)
Musculoskeletal (1)
Myocardial ischaemia (1)
Myocardial perfusion imaging (1)
Myocardial SPECT indices (1)
Nanomedicine (1)
Nanoparticles (1)
National professional examination (1)
Native mass spectrometries (1)
Native MS (1)
Neoformans (1)
Neuroendocrine tumour (NET) (1)
Neurologic examination (1)
Nigeria (1)
Nitroimidazoles (1)
Non-prostate carcinoma (1)
NOTA (1)
Nota-RGD (1)
Nuclear safety (1)
Parathyroid (1)
Patient treatment (1)
Patienten management (1)
Pedicle screws (1)
Peptide radiolabeling (1)
Peptide receptor radionuclide therapy (PRRT) (1)
Performance improvement (1)
Personalised medicine (1)
PET imaging (1)
PET/computed tomography (1)
PET/CT imaging (1)
PET/CT-imaging (1)
Phenylacetic acid metabolism (1)
Physico-chemical characterization (1)
Plasma homocysteine (1)
Poly(D,L-lactide-co-glycolide) (PLGA) (1)
Positron emission tomography/computed tomography (PET/CT) (1)
Primary prostate carcinoma (PPC) (1)
Professional practice standards (1)
Prostate-specific antigen (PSA) (1)
Prostate-specific membrane antigen radioligand therapy (PSMA-RLT) (1)
Protein (1)
Proteins (1)
Pulmonary (1)
Quality control (1)
Quality improvement (1)
Racial differences (1)
Radiation (1)
Radioiodine therapy (1)
Radiolabeled (1)
Radiolabeling (1)
Radioligand therapy (1)
Radionuclide therapy (1)
Radionuclides (1)
Radiotracers (1)
Receptor radioligand therapy (RLT) (1)
Recipients (1)